A study investigating the prognostic role of serum albumin in patients with ovarian cancer treated in an integrative cancer treatment setting found that every one gm/dL increase in serum albumin was associated with a RR of 0.39 (95% CI: 0.29 to 0.53; p < 0.001) [77]. The gene discussed is ALB; the disease is ovarian carcinoma.